Download full-text PDF

Source
http://dx.doi.org/10.1093/ced/llad118DOI Listing

Publication Analysis

Top Keywords

comment 'onset
4
'onset epidermolysis
4
epidermolysis bullosa
4
bullosa acquisita
4
acquisita therapy
4
therapy ustekinumab
4
ustekinumab treatment
4
treatment crohn
4
crohn disease'
4
comment
1

Similar Publications

Author's reply: Comment on: "Paediatric-onset autoimmune liver disease: Insights from a monocentric experience".

Dig Liver Dis

January 2025

NEUROFARBA Department, University of Florence, viale Gaetano Pieraccini 6, 50139 Firenze, Italy; Meyer Children's Hospital IRCCS, viale Gaetano Pieraccini 24, 50139 Firenze, Italy.

View Article and Find Full Text PDF

The toxicokinetics of nitrosamines remain a mystery to this day, though it appears that the role of nitrosamines in potentiating the generation of mutations required for the onset of skin cancer continues to be a significant concern. Nitrosamines are mutagens, genotoxic substances, and mediators of phototoxicity/carcinogenicity, whose long-term daily usage, in the context of polypharmacy, can result in the parallel appearance of heterogeneous forms of skin cancer: keratinocytic and melanocytic. But a number of clinical observations suggest that it is the nitrosamines that potentiate the multiple occurrences of skin cancer over the years, or recurrences of skin cancer localized in areas exposed to solar radiation.

View Article and Find Full Text PDF

Objectives: Although bluetongue is not a contagious disease, it is easily transmitted and spread by appropriate insect vectors, causing great economic damage. Climate change has led to the fact that vectors and diseases have spread to the top of Northern Europe, causing great economic losses in livestock production. An even greater problem is controlling the disease, because numerous species of domestic and wild ruminants are susceptible to bluetongue.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!